Tilia Fe
Product Images NDC 21695-685

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tilia Fe (NDC 21695-685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formulas Of Norethindrone Acetate And Ethinyl Estradiol (3cb9494c 4d70 4ebd 98ec 0e28021c1fee 01)

Chemical structures of two steroid-related compounds are shown, likely representing active ingredients or metabolites. Each molecule has multiple fused rings, with distinct functional groups including hydroxyl (OH), acetyl (OCOCH3), and alkyne (C≡CH) substituents visible on the structures.*

FDA Label Image

Mean Plasma Concentration Vs. Time (3cb9494c 4d70 4ebd 98ec 0e28021c1fee 02)

Two line graphs showing mean steady-state plasma concentrations of Ethinyl Estradiol (top) and Norethindrone (bottom) over 24 hours after chronic administration of Norethindrone Acetate and Ethinyl Estradiol tablets. Concentrations are plotted for three different formulations labeled 1/20, 1/30, and 1/35, with time in hours on the X-axis and concentration units on the Y-axis.*

FDA Label Image

Mean Percent Reduction Vs. Cycle (3cb9494c 4d70 4ebd 98ec 0e28021c1fee 03)

A line graph showing mean percent reduction in total lesion counts over six 28-day cycles. The graph compares placebo and norethindrone acetate with ethinyl estradiol tablets in an intent-to-treat population, indicating percent reduction from baseline with both treatments increasing over time, with no statistically significant differences until cycle 6.*

FDA Label Image

Mortality Rates (3cb9494c 4d70 4ebd 98ec 0e28021c1fee 04)

A bar chart titled 'Figure 3: Circulatory Disease Mortality Rates Per 100,000 Woman Years by Age, Smoking Status, and Oral Contraceptive Use.' It compares mortality rates for ever-users and controls among non-smokers and smokers across four age groups: 15-24, 25-34, 35-44, and 45 and older. Mortality rates increase with age, with the highest rates observed in ever-users who are smokers aged 45 and above.*

FDA Label Image

Pill Pack Image (3cb9494c 4d70 4ebd 98ec 0e28021c1fee 05)

Tilia Fe monthly self-release team tablet blister pack with active and placebo tablet layout. Includes instructions for use starting on day 1 based on the menstrual cycle, with designated days of the week labeled from Sunday to Saturday. The pack shows active tablets and placebo tablets clearly labeled in rows and instructions for proper usage.*

FDA Label Image

Pill Pack Image (3cb9494c 4d70 4ebd 98ec 0e28021c1fee 06)

The image shows the blister pack label for Tilia Fe by Rebel Distributors Corp, NDC 21695-685. It is a weekly oral tablet pack arranged by day and week, including active tablets containing norethindrone acetate, ethinyl estradiol, and ferrous fumarate, plus placebo tablets for week 4. Instructions guide day-1 starters to align the day label strip starting from the first day of their period.*

FDA Label Image

Tilia Fe (3cb9494c 4d70 4ebd 98ec 0e28021c1fee 07)

Label for Tilia Fe Triphasic 28-Day Regimen Tablets, containing 28 tablets per package. Distributed by Physician Partner and manufactured by Watson Laboratories, Inc. The label includes storage instructions, a lot number, expiration date, and a barcode. It also indicates the product is prescription only (RX Only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.